Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 48, Issue 10, Pages 3779-3781Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01236-10
Keywords
-
Categories
Funding
- U.S. Centers for Disease Control and Prevention [5U52 PS900515-27]
Ask authors/readers for more resources
To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
